Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.98 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XPNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CQ.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.311NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.93NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.104NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.225NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.105NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.307NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.171NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AD.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.201NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
W.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.5 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
C.36.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.525 (Eta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.1.193NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.1.377NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used